Month: January 2012

Oral B Pro Health Clinical Sensitive

Designed for people with dental hypersensitivity, the new toothpaste of Oral-B offers immediate relief and combat effectively the sensitivity in the long term.

the formula of the new Oral-B Pro-Health Clinical Protection Sensitive brings as main ingredient the stannous chloride, which, associated to the other active principles of product, helps block the openings of small tubules (MicroChannel plates having a) connected to nerves of the tooth, inhibiting the movement of the fluid and preventing external agents activate pain.

the component operates from the first brushing, providing instant relief. With continued use, significantly reduces the sensitivity, lasting manner, because it creates a barrier effect, a kind of protective shield on the surface of the enamel of the teeth, avoiding acid erosion (damage to the teeth by acids, often from food). This is possible thanks to the Association of stannous chloride to sodium gluconate, which increases the bioavailability (absorption index and speed) of stannous chloride.

This formula of Oral-B Pro-Health Clinical Protection Sensitive sodium fluoride, brings the added benefit of superior protection against tooth decay. The ingredient improves remineralization of teeth, increasing incorporation of calcium and phosphate ions in enamel and/or dentin damaged. The structure of enamel formed after the incorporation of fluoride, fluoroapatita, increases its resistance against a future

demineralization.

about three out of four people have some sort of teeth sensitivity. “Studies indicate that, immediately after use, Oral-B Pro-Health Clinical Protection Sensitive provided immediate relief of sensitivity, acting more quickly than other creams on the market that have the same purpose. The benefit was even greater after three days of use, demonstrating that the product plays in protecting against the causes of sensitivity in the long run, “says Dr. Walter Bretz, professor in the Department of Karyology of the Faculty of Dentistry of the University of New York.

Oral-B Pro-

Health Clinical Protection Sensitive also contains Pítico Acid and zinc, which offer benefits anticálculo, because they act by inhibiting the growth of calcium phosphate crystals formed when calcium and phosphate are joined together. These crystals eventually harden within the plate, forming the calculation. The Pítico Acid still collaborates to avoid formation of stains on the surface of the tooth. Completing the formulation, the product brings the Hydrated Silica, which acts on the control of spots, completing the careful with areas that dentists more check, which include decreased sensitivity, fight against cavities, beware of the gums, tartar control, improving breath, combating the accumulation of plaque and stain removal

.

 

. oralb.br/>

Read More

2011 Balance very positive for the CIOCC, with 2,300 new and 330 patients in clinical trials.

Balance of 2011 very positive for the Ciocca, with 2,300 new and 330 patients treated in clinical trials.

Care and research data center consolidate it as reference oncology unit at national and international levels.

– The volume of patients seen in the CIOCCA in 2011 has increased 22 percent over the previous year, which meets the objectives set for the year just ended, and is now comparable to that of the major public hospitals the Community of Madrid

– Patients treated and the latest technologies, with the best diagnostic and therapeutic methods, which are made available to allow the CIOCCA multidisciplinary and personalized medicine class

– The director of CIOCCA described as “spectacular” the percentage of patients treated in clinical trials, 15 percent of the total (one third of the latter in Phase I)

– Next to the Hospital Vall d’Hebron (Barcelona), the CIOCCA is a center of reference and research at European level in Phase I and is the only one of the Community of Madrid with a consolidated program of experimental therapy

– For 2012 the CIOCCA includes the objective of serving 2,500 patients and treated 400 new clinical trials, 20 percent more this year

– Unit of Hematology and Oncology attended in 2011 to 168 new patients and 1574 review consultations and 833 administered chemotherapy treatments. Hospital admissions totaled 433, with an average stay of 4.78 days, and treatments at the Day Hospital to 902

– The actuarial survival of cancer patients treated in the service is more than 81%, according to the National Registry of Childhood Tumours of Spain

Madrid, January 2012 .- Comprehensive Cancer Center Clara Campal (CIOCCA) has closed 2011, its fourth year of activity, with a balance “very positive” in the words of its director, Dr. Manuel Hidalgo, and that concrete an average of 2,300 new patients per year and 330 (approximately 15 percent) including clinical trials, one third of which has been in Phase I research, that is, early clinical studies conducted with novel drugs.

The results of Ciocca, both of medical care for patients and results in them, as at the research, strengthen the center’s oncology unit reference as nationally and internationally.

According to figures provided by Dr. Hidalgo, “the volume of patients seen in the CIOCCA has experienced growth rates well suited since the launch of the center in 2011 increasing 22 percent over the previous year, which meets the objectives set for the year just ended, and is now comparable to that of public hospitals as the Gregorio Maranon and La Paz. ”

 

Research activity

On the research input of the center, its director describes as “spectacular” the percentage of patients treated in clinical trials, “the level of the best American schools, which is already a clear and positive contribution, first in terms of good Treatment of these patients, and secondly, in terms of our contribution to scientific progress. ”

Approximately one third of the 330 patients, ie 120, they have done in Phase I studies, “CIOCCA being the only center of Madrid, public or private, with a consolidated program of experimental therapy,” added Dr. Hidalgo, stressing that the center is, near the Hospital Vall d’Hebron (Barcelona), the only nationally and clearly as a reference center and at European level in a type of research, Phase I, which does not directly exists in the Spanish public health. ”

Objectives for 2012

For this year 2012 CIOCCA forecasts suggest even higher and, following the progression of growth that has registered so far, includes the objective of serving 2,500 patients new to the center and try to 400 in clinical trials, 20 percent in 2011. This director has his key allies as “a very good portfolio of studies for this year and unquestioned support of the pharmaceutical industry, required for Phase I trials.”

“Our portfolio highlights some studies, as, surely, the new version bevacizumab, the onset of viral therapy trials and oncolytic viruses, and deepening of an even more intense in our program of personalized medicine,” he adds.

One of the key considerations in dealing with cancer is to provide highly personalized treatments based on the molecular profiles of each tumor to address a challenge of the CIOCCA Oncology also shares and which will further work, for which it is need for new molecules.

“We have a pretty good collection of molecules, and a very important support for this in the pharmaceutical industry, especially foreign, has chosen our center for conducting research with innovative molecules, as evidenced by the fact that some companies large pharmaceutical and consolidated entrusted to CIOCCA molecules in its first foray outside the United States for the development of Phase I clinical trials, “he concludes.

Data in Oncology

Meanwhile, the Unit of Hematology and Oncology (UHOP) HM Hospitals, dependent and located in HM CIOCCA Montepríncipe University, has continued in its fifth year of operation on an upward trend, both in dealing with patients as Hematology Pediatric Oncology.

According to data provided by Dr. Blanca Lopez-Ibor, director of the service, which will cater for children up to age 19 years of a multidisciplinary, covering health and psychosocial area in 2011 “in 2011 unit 168 new patients attended (20 per cent of Oncology) and 1574 review consultations and 833 administered chemotherapy treatments. ”

As for hospital admissions last year amounted to 433, with an average stay of 4.78 days (90 per cent of oncological), while the treatments in the Day Hospital was 902, she adds , indicating also that the unit has carried out seven transplants of bone marrow and two treatments with I-131 MIBG (metaiodobenzylguanidine labeled with I-131) in coordination with the Nuclear Medicine Department Ciocca, the center also have undergone radiation therapy to twelve pediatric patients.

Read More

CIPF and the FIVAN Foundation organized the II International Neurorehabilitation Symposium.

The IPPC and the FIVAN Foundation organized the II symposium international de Neurorehabilitation.

the event will be held at CIPF during the month of October.

– in the Valencia region are 8,500 people with a high risk of sequelae after an acquired brain injury

-the Symposium will address the Neurorehabilitation from a multidisciplinary approach covering from basic neuroscience to the Neurotechnology

Valencia, January 2012.- El Centro de Investigación Prince Felipe (CIPF) and the Valencian Institute Foundation of Neurorehabilitation (FIVAN) organized the Second Editionón International Symposium on Neurorehabilitation: From Basics to Future, which will take place in the Research Center Prince Philip from 18 to 20 October 2012.

The increase of acquired brain damage (DCA) in recent years represents a complex problem of health around the world. Only in the Valencian Community, according to a recent study carried out by the FIVAN Foundation and Superior Research Center in public health (CSISP), it is estimated that there are 8,500 people a year are given high after a DCA and a high risk of sequelae.

The complexity in the approach of the pathology in these patients requires a multidisciplinary approach to take as a starting point the important advances occurring in such fields as information technology and communication (ICT ’ s), virtual reality and robotics. Also, in the study of the DCA experimental scientific advances are relevant (biochemical, genetic, functional, etc); and also the clinical (pharmacological, early intervention, etc.). In this sense, the Congress is a meeting place for outstanding professionals to establish synergies between different fields which you can can be approximations of interest to the progress of research in Neurorehabilitation.

As points out Dr. Javier Chirivella, President of FIVAN and scientific director of the event, “ after the success of the first edition of the Congress in 2009 with more than 400 registered from 30 different countries, from the FIVAN Foundation have seen the need to unite basic neuroscience, clinic and Neurotechnology with the idea of improving health care models and encourage engineering in Neurorehabilitation ”.

An event of great international projection

For three days, international experts reviewed the current status of Neurorehabilitation and recent advances in the field. The Organization of the event will allow the participation of attendees with the aim of promoting research worldwide activity carried out in research centres, companies and universities, that will show their latest developments.

The Organization of the event shall be borne by the Ministry of health as an institution responsible for the implementation of the results through the network of hospitals in the region of Valencia; FIVAN as an entity specializing in research in Neurorehabilitation; and the CIPF as a research centre and venue chosen for the Congress venue.

As partners are the higher Centre for research in public health, which has contributed to the development of studies of data through its epidemiological monitoring centre; and the Institute of ITACA r & d of the Polytechnic University of Valencia, which supports the event through different inputs from studies and projects associated with patients with acquired brain damage and applied technology research.

Read More

FEDIFAR considered exhausted the route of pharmacy pharmaceutical spending cuts to sustain the SNS.

FEDIFAR considered exhausted the route of pharmacy pharmaceutical spending cuts to sustain the SNS.

down the invoice in drugs in 2011 a 8.78%. Joins the 2010 fall
from 2.36%

-the patron saint of pharmaceutical distribution (FEDIFAR) considers that the contribution of the pharmaceutical sector to the sustainability of the national health system is unquestionable and clearly enough

-sector has undergone in 2010 and 2011, at the State level, of very harsh measures which have placed the companies on the verge of its viability. For pharmaceutical distribution, these cuts have resulted in a minimum of approximately 1.8 billion euros less than billing

-FEDIFAR requests and health authorities to consider other avenues of health care cost containment alternatives to cut the public Bill in medicines based on structural measures to improve the efficiency of the SNS in the medium and long term to ensure the survival of the health care model Spanish and the related companies

Spain, January 2012- the Spanish pharmaceutical distribution Federation (FEDIFAR) through cuts in spending on Drugs considered exhausted to sustain the national system of health (SNS). The central and regional Governments have reduced the public Bill in medicines by 2.36% in 2010 and 8.78% in 2011, according to figures announced last Friday by the Ministry of health, social services and equality.

For FEDIFAR pharmaceutical sector to the sustainability of the SNS’s contribution is more than enough and it has already been more than demonstrated the commitment of the sector with the difficult economic situation affecting the country.

Continue elaborating on cuts in the Bill on drugs would be the final blow to businesses with its viability already compromised, with the consequent loss of employment and investment, which is the last thing that needs Spain.

Pharmaceutical distribution companies already took a hit which has meant less income € 1,190 million in 2010. And new measures by the Government in 2011 will be minimal impact of approximately EUR 600 million for distribution, and a planned overall saving of 2.4 billion, which will be subtracted from the income of the sector. This adds up to the constant cuts prices and margins (set by law) in recent years.

If to this we add delays and defaults of the public Bill for medicines that pharmacy (and, consequently, the distribution companies) are experiencing in some autonomous communities, the scenario is complicated.

less accessibility to the drug

and in the health sector, the closure of distribution companies would lead to that citizens be diminished its accessibility to treatment, is the pharmaceutical distribution of full range the responsible for taking all medications at all times and to all corners of the country by remote than are

Thus, FEDIFAR requests the Ministry of health and the ministries of industry that not abundant in cuts in the public Bill on drugs to be sold in pharmacies (is the heading to which they refer official data and the more controlled).

Likewise, the Federation requested that alternative ways of improving efficiency in the NHS explore. The sample that there are way to go in the rational use of medicines is that, despite lower bills a 8.78%, the number of prescriptions has continued to rise (1.62% in 2011), so there is room for progress in demand and fail to act on the offer (agents of the sector).

For FEDIFAR, the sustainability of the passes SNS for efficiency, but also to devote adequate resources for the financing of health care, and notes with concern that the majority of CCAA have budgeted for 2012 below the cost of 2011 health in general and pharmaceutical in particular. The concern is greater if one takes into account that the CCAA does not steps are being taken of draught in the improvement of efficiency alternatives to actions in the field of medicine.

The Federation has proposed to the Ministry and the autonomous communities the joint search for solutions that do not harm the economy of the companies in the sector. more

who we are

the Federation of pharmaceutical distributors (FEDIFAR) is composed of 52 wide range distribution companies, with a combined market share above 97%.

High-end pharmaceutical distribution makes it possible that the entire Spanish population has equal access to medicines irrespective of the place where they reside. His activity means that all pharmacies of the territory receive equal all drugs marketed in Spain.

To achieve this, the distribution of wide range is based on the solidarity model of distribution: detract benefits of expensive products and high rotation to subsidize the service of cheap products and low rotation.

Read More

When the children want to or need to live with the parent not cohabitant

when children want to or need to live with the parent not common-law

campaign of APADESHI, in family conflict prevention

Buenos Aires, January 2012.- in a separation or divorce, with minor children, up to 5 years except for very serious situations which desaconsejara it, legally the possession of the children is awarded to the mother and after that age continues the same criterion in the courts, although he began to see various possibilities that tenure is exercised by the parent not common-law at the behest of the children, by decision or need for help.

It may be situations in which children, pose a scenario in which, to continue with the parent cohabitant, is complicated, and may be present experiences of abuse, violence, neglect, physical risk and / or psychological, and it is noted the possibility of a change of guard.

A common question is when children can decide? children must be heard by the judges, advisors or advocates for children with psycho team of court intervention, assessing the context surrounding the exhibition.

when what you want a son is decision-making?

When his conviction is so strong, that before a psychological expert, and heard by the judicial authorities, maintains its determination to consistently, appreciate that not impregnated by induction, anyone who contaminates the discourse of the child.

The strength of the decision of a son who aspires to live with the other parent, is determined by the time which really decides and has ability to move on their own and should be reinstated by the courts to the home of the parent cohabitant, will reiterate his attempt to transfer to the House of the parent with whom you want to live.

Before the conflict in a situation of possible repeated breaks, determined that the Court exposed to a reality, which exceeds the participation of the elderly, should avoid the danger of this wandering, noting whether the conditions of the parent who would receive are adequate to resolve the change of guard.

do you can do the parent no common-law before the externalisation of the son, you need to withdraw from the home by being exposed to situations of physical hazards and / or psychological?

Submit a preventive measure not innovate if it is found with the child who does not wish to return to the parent cohabitant, saved and is not a whim or anger of the moment and it should safeguard their physical and psychological integrity.

If it is due to an issue of protection against an abuse, violence, injuries, featuring justice “ risk ”, providing evidence that possesses and witnesses. The testimony of the minor will be evaluated and assessed by the intervening Court. The judicial presentation must be immediate, avoiding the possible denunciation for retention of the son, who is in a position to carry out the parent in charge of the Legal ownership or fact and which would complicate the investigation with a hasty return without taking the necessary measures of protection.

If resolution by the Court were negative change of custody, the child must return with the parent cohabitant and if it maintains the decision not to continue coexistence, the parent in its assistance may insist that will review the granting of custody change, avoiding a possible leak of the home, in which the child no longer want to stay, and the risks that such an attitude could lead to him.

In these cases is where the main concern of the courts, on protection of minors, being fundamental and indispensable to maintain within the legal framework can be seen.

-Another option is approaching the Ombudsman’s Office or children’s advice, and ask be cared for and that child or teenager expresses the because does not want to stay more with the other parent cohabitant. In response to the sayings of the child, to take the relevant legal documents or well discouraging change in custody be considered that he does not fulfil the conditions to produce one. There will be skills in order to verify the psychological state of the minor and the credibility of the above.

In pre adolescents and adolescents, the witness has a high assessment by the Court. In younger children, the willingness of the courts is not to modify the State of tenure, except that there were situations of violence, with the proper identification.

Before the claim of the sons to change their guardian, the right thing is dialogue with the other parent and not go to legal extremes. Both parents must understand that the change of custody does not mean losing the link, but a change of address, and there is no questions that desaconsejaran, keep the link and communication.

-When the children are able to decide with whom to live together, they have no doubts, that want to know is how to do it and them to be support from the personal and legal.

– If present fears, doubts or repair, before proceeding to a legal body, it is to verify the reasons and if he is not an anger momentarily.

-The sense of possession upon the children often inhibit the reasoning, and is where the intervention of Justice can accommodate history and protect the right of each of the components of the family group in conflict.

For the granting of the change of guard, there are some guidelines that can serve the judge to consider the best interests of the child. Some of them are:

– give priority to the coexistence of the brethren; avoiding producing a new Division family.

-Listen to children; While your opinion is not conditioning factor for the judge, it is important because of the testimony of the minor, offers the judge the possibility of a bigger picture at the time of the judgment, in the observation that the assertions of the parents, they are not always objective.

-Keep the context pre – existing: principle assumes convenient to not produce modifications or transfers, because that can affect the child. A change of temporary possession gives rise to a period of study, in order to determine a final tenure.

-Some of the elements that guide the judge to change resolution of

foster, the age of the minor, the positive or negative influence that can have on the child of parents attitudes.

If the parent not cohabitant notes that the child has been abused, injuries, it should be directed to the health unit more close, ask for the intervention of a medical forensic, a psychologist and denounce the fact. If you have a lawyer, make contact immediately, presenting a measure precautionary care.

In some municipalities there are areas related to the promotion and defence of the rights of the child, which also is available, in situations in which their rights are violated or in circumstances of risk, asking for their collaboration.

Read More

Surah Al-Rehman – The Ultimate Free Remedy for Incurable Diseases

(By Listening Only- 20 Minutes Only)

Kindly download the Surah “AL-REHMAN” (recited by Qari Abdul Basit without translation) from here.


Treatment Plan

Just Listen to it three times a day (morning, afternoon, evening) for seven consecutive days using following procedure:-


    Before listening:

  • Close your eyes
  • Feel your self in front of ALLAH Almighty/ God
  • Then listen to it with greater concentration and closed eyes

    When the recitation/ AUDIO is finished:

  • Open your eyes and take half glass of water
  • Close your eyes again and say “ALLAH” three times in your heart with deep affection/ love
  • Then drink the water with closed eyes in three sips

Surah Al-Rehman – The Ultimate Free Remedy for Incurable Diseases

(By Listening Only- 20 Minutes Only)

Kindly download the Surah “AL-REHMAN” (recited by Qari Abdul Basit without translation) from here.


Treatment Plan

Just Listen to it three times a day (morning, afternoon, evening) for seven consecutive days using following procedure:-


    Before listening:

  • Close your eyes
  • Feel your self in front of ALLAH Almighty/ God
  • Then listen to it with greater concentration and closed eyes

    When the recitation/ AUDIO is finished:

  • Open your eyes and take half glass of water
  • Close your eyes again and say “ALLAH” three times in your heart with deep affection/ love
  • Then drink the water with closed eyes in three sips